Objective: To investigate serum paraoxonase (PON1) activity, serum calcium, and lipid profiles in pre-eclampsia. 
INTRODUCTION
Pre-eclampsia is a defined as pregnancy-induced hypertension (systolic blood pressure> 140 mm Hg and diastolic blood pressure > 90 mm Hg) with proteinuria (either ≥ 300 mg protein per day or an urinary protein/creatinine ratio ≥ 30 mg/mmol) occurring after 20 weeks of gestation. Although this definition uses readily measured clinical parameters, pre-eclampsia must be recognized as a multisystem disorder that may affect the brain, lung, kidney, and liver (1, 2) .
Pre-eclampsia affects between 0.4% and 2.8% of all pregnancies. This common disorder is associated with the highest maternal and fetal morbidity and mortality of all pregnancy complications (3) . The cause of preeclampsia remains unknown, but endothelial cell dysfunction is a key feature of its pathogenesis. The cause of the endothelial cell injury is probably multifactorial, but poor placental perfusion plays a major role. In pre-eclampsia, characteristic pathological lesions in the placenta consisting of fibrin deposits, and acute atherosis and thrombosis are present.
Abnormalities in lipids are known to be strongly associated with atherosclerotic cardiovascular disease and have direct effects on endothelial function.
Abnormal lipid metabolism seems important in the pathogenesis of pre-eclampsia as well (4) . Normal pregnancy is characterized by an elevation of the plasma levels of free fatty acids, triglycerides, cholesterol and low density lipoprotein (LDL) cholesterol (5) (6) (7) . In pre-eclampsia, even higher levels of triglycerides and lipoproteins may be present (8, 9) .
High levels of triglycerides generally lead to the formation of smaller LDL particles, which are more prone to oxidative modification (6) . Oxidatively modified LDL has been shown to play a role in the impairment of vascular endothelial cell function during atherogenesis (9) , and may also be involved in the development of pre-eclampsia.
Paraoxonase (aryldialkylphosphatase, E.C 3.1.8.1, PON1) is a serum esterase synthesized in the liver.
The enzyme was originally found to be responsible for the hydrolysis of paraoxone, a toxin that irreversibly inhibits acetyl cholinesterase (10) (11) (12) (13) (14) . PON1 circulates as part of high density lipoprotein (HDL) particles in the blood of humans. The enzyme is tightly bound to the hydrophilic N-terminal domain of Apo-AI. Recently, PON1 has been shown to inhibit the oxidative modification of LDL (15) , and it is considered to be an antioxidant enzyme with a protective role in atherosclerosis (16) . PON1 can destroy active lipids in mildly oxidized LDL, thereby preventing the induction of inflammatory responses in endothelial cells. PON1 is strictly dependent on calcium for enzymatic activity (17) (18) (19) .
In the present study, we investigated the relationship among serum PON1 activity, serum calcium concentration, and lipid profile in patients with preeclampsia.
MATERIAL AND METHODS
The study was conducted at the Department of Obstetrics and Gynecology of Dicle University Faculty of Medicine.
Thirty-four women with pre-eclampsia and 11 women with normal, normotensive pregnancies were prospectively followed. All of the study related procedures were subjected to local ethics committee approval and the study All patients had neither pre-existing hypertensive disorders, nor any renal, hepatic or hematological diseases, and they did not receive any medication.
None of them were smokers.
Blood samples (approximately 10 ml) were subjected to centrifugation at 4000 x g for 10 minutes at room temperature. Serum samples were collected and stored at -20°C for one week. PON1 activity was determined as described by Jureticé D et al (21) . Initial rates of Mann-Whitney U test was used to identify differences between the groups. Data was given as mean ± S.D.
Differences were considered significant when P < 0.05. Table I shows the demographic characteristics of the patients. There were no differences in age, parity, and gravidity between the two groups. As expected, women with pre-eclampsia had significantly higher systolic (P < 0.001) and diastolic blood pressures (P < 0.001).
RESULTS
Gestational age tended to be lower in women with preeclampsia.
Women with pre-eclampsia had significantly higher levels of hemoglobin, hematocrit, serum AST, ALT, and LDH than normotensive pregnant women (P <0.001; Table II ). Compared to normotensive women, women pre-eclampsia showed lower serum platelet counts (P < 0.01).
Triglycerides, total cholesterol, and LDL-cholesterol Changes in serum paraoxonase activity, calcium and lipid profiles in pre-eclampsia, a preliminary study concentrations were significantly increased in women with pre-eclampsia, compared to normal pregnant women (Table III) . Serum HDL-cholesterol, PON1
and calcium levels were lower in pre-eclamptic than in healthy pregnant women (P < 0.05).
In addition, normotensive women had no sings of any complications of pregnancy, and all gave birth to healthy infants.
DISCUSSION
Pre-eclampsia is one of the most serious complications of pregnancy. The causes of pre-eclampsia are unknown, but evidence suggest that it results from maternal vascular endothelial dysfunction (22) . Since concentrations of LDL in pre-eclampsia (23, 24) .
Wakatsuki et al. reported that, LDL and HDL particles
were more susceptible to oxidative modification and plasma concentration of LDL particles but not of HDL particles was increased in pre-eclampsia (9) .
In our study, serum total cholesterol, LDL cholesterol, and HDL cholesterol levels were significantly different between pre-eclamptic and normal pregnant women.
Triglycerides, total cholesterol and LDL cholesterol concentrations were significantly increased in women with pre-eclampsia, compared to women with normal pregnancies. This significant elevation in lipid levels in pre-eclampsia is consistent with several previous reports (25, 26) . In addition, serum calcium levels were significantly lower in pre-eclamptic women. Because PON1 requires calcium ions for both activity and stability, it is tempting to speculate that low calcium might be the cause of decreased PON1 activity.
However, there is no available data to support this hypothesis at present. Nevertheless, our findings confirm that low serum PON1 are present in preeclampsia.
Human pregnancy is associated with pronounced physiological hyperlipidemia and the normal gestational increase in triglycerides is associated with a change in LDL profile toward smaller, denser species (27) . The elevated serum concentrations of triglycerides and lower concentrations of HDL cholesterol found in preeclampsia patients are in good agreement with the results of other studies (27, 28) . The elevated concentrations of serum triglycerides in pre-eclampsia can be explained by higher levels of free fatty acid in conjunction with reduced hepatic beta-oxidation, enhanced peripheral insulin resistance, and reduced catabolism of triglycerides (27) . 0,001) (30) .
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The results of our study suggest that an abnormal lipid profile and a decrease in the activity of lipophilic antioxidant paraoxonase may play a role in the pathogenesis of preeclampsia through increased susceptibility to lipid peroxidation. Further research is needed to clear the mechanism of this contribution.
